Video gallery

Aktiespararna intervjuar VD Martin Jönsson – senaste kvartalsrapporten och framtidsutsikterna. 20 september, 2021

AlzeCure Pharma – Aktiedagen Stockholm, September 7 2021

Strategy Update on Alzheimer’s Disease & NeuroRestore, September 1, 2021

Alzheimer’s disease and the neurotrophins BDNF/NGF by by Prof. Maria Eriksdotter M.D., PhD, Prof, September 1, 2021

Company Overview & Vision by Martin Jönsson CEO, September 1, 2021

NeuroRestore Background and evolution by Dr Pontus Forsell, PhD Head of Discovery & Research, September 1, 2021

Development plan for NeuroRestore ACD856 by Dr Johan Sandin, PhD Chief Scientific Officer, September 1, 2021

Om AlzeCures uppkomst och utveckling – Ett embryo som kan bli något stort –

med Bengt Winblad, professor, senior vid Karolinska Institutet

Om Alzstatin och läkemedel vid Alzheimers sjukdom –

med Bengt Winblad, professor, senior vid Karolinska Institutet”

Om att drabbas av Alzheimers sjukdom, diagnostik, vården idag samt framtida behov –

med Bengt Winblad, professor, senior vid Karolinska Institutet”

Negative Allosteric Modulators of TrkA for the Treatment of Pain – Scientific presentation at the IASP conference on pain, June 2021

Alzecure: CEO Martin Jönsson present at Redeye Growth Day

TrkA- NAM – Project in osteoarthritis & other severe pain conditions Head of Discovery & Research Pontus Forsell

ACD 440 – A novel VR1 antagonist for neuropathic pain CSO Johan Sandin

Chronic Pain – a high unmet medical need CMO Märta Segerdahl

Company overview and goals CEO Martin Jönsson

CEO Martin Jönsson after the company’s annual meeting

Interview with Martin Jönsson CEO in Aktiespararna’s analysis guide

CEO Martin Jönsson presentation, Aktiedagen Lund

Interview with Johan Sandin (CSO) in Aktiespararna’s analysis guide

AlzeCure Pharma provides a scientific update on Alzheimer’s disease and the Alzstatin project platform

Presentation with Redeye – Science & Market update – September 1, 2020

Welcome to AlzeCure…

CEO presentation video – Annual meeting May 20 2020 (Swedish)

Lär känna vd Martin Jönsson – Redeye Research Interview March 19, 2020 (Swedish)

Aktiedagen March 16, 2020 (Swedish)

About Alzstatin

About Alzheimers disease

About NeuroRestore